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Introduction
Macrophage activation syndrome (MAS) is life-threatening
complication of rheumatic diseases and is most frequent
seen in systemic juvenile idiopathic arthritis (sJIA). Prompt
recognition and immediate therapy is life saving.
Objectives
To review clinical and laboratory data of MAS in 7
children with sJIA.
Methods
Clinical and laboratory data of 7 patients with MAS, trea-
ted in our hospital from January 2008 to December 2013,
were analyzed retrospectively.
Results
Seven children (4 females, 3 males) were studied. Two
children had incomplete MAS. The underlying disease
was not identified in one child. MAS developed during the
course of underlying disease (sJIA) in three children. Clini-
cal manifestations at diagnosis included high persistent
fever (7), skin rash (6), hepatosplenomegaly (7), lymphade-
nopathy (6), hemorrhages (5) and central nervous system
dysfunction (6). Laboratory data included: high feritin
>10 000 (7), cytopenia (7), abnormal liver function tests
(7), hypoalbunaemia (7), hypertriglyceridemia (5), coagulo-
pathy (5), decreased erythrocyte sedimentation rate (5).
Macrophage hemophagocytosis were found in 4 bone
marrow aspiration. Rota virus was isolated in stool in
3 children. MAS was reccurent in two children (perforin
gene done, negative). Six children responded on immuno-
supressive therapy and are doing well, one child died.
Conclusion
MAS is rare but serious complication of systemic juvenile
idiopathic arthritis in children. It is important to keep in
mind suddenly clinical and laboratory disturbanses in
children with JIA, to recognise and immediate treat MAS
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